Regor Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

Regor Therapeutics General Information

Description

Developer of biopharmaceutical technology focused on oncology, metabolic diseases and autoimmune diseases. The company is dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development.

Contact Information

Website
www.regor.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 10
  • Number 1206 Zhangjiang Road, Pudong New Area
  • Shanghai, 201210
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Building 10
  • Number 1206 Zhangjiang Road, Pudong New Area
  • Shanghai, 201210
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regor Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 11-Dec-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 18-Feb-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 04-Jul-2018 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Regor Therapeutics’s complete valuation and funding history, request access »

Regor Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lilly USA Corporation Minority
LanTing Capital Growth/Expansion Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Loyal Valley Capital Growth/Expansion Minority
TF Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Regor Therapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Regor Therapeutics (Portfolio of Cyclin-Dependent Kinase Inhibitors)

Regor Therapeutics FAQs

  • When was Regor Therapeutics founded?

    Regor Therapeutics was founded in 2018.

  • Where is Regor Therapeutics headquartered?

    Regor Therapeutics is headquartered in Shanghai, China.

  • What industry is Regor Therapeutics in?

    Regor Therapeutics’s primary industry is Drug Discovery.

  • Is Regor Therapeutics a private or public company?

    Regor Therapeutics is a Private company.

  • What is Regor Therapeutics’s current revenue?

    The current revenue for Regor Therapeutics is .

  • How much funding has Regor Therapeutics raised over time?

    Regor Therapeutics has raised $90M.

  • Who are Regor Therapeutics’s investors?

    Lilly USA, LanTing Capital, LAV (Lilly Asia Fund), Loyal Valley Capital, and TF Capital are 5 of 8 investors who have invested in Regor Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process